Ehret, F., Abid, F.B., Ribeiro, V.T., Bodden, R., Maluf, F.C., Larco-Castilla, P., Naud, L.M., Ferraz de Paula Soares, C., Shaikh, E., Valente de Camargo, L. and Ridolfi, F.M. 2020. The IDEAL trial - a study protocol for a phase III randomized, double-blinded clinical trial assessing the ultra-short antibiotic prophylaxis of Isoniazid and Rifapentine in non-immunosuppressed patients with newly diagnosed latent tuberculosis. Principles and Practice of Clinical Research. 6, 1 (May 2020), 9–14.